常见宿主基因组变异在儿童急性淋巴细胞白血病中的作用
本文综述儿童急性淋巴细胞白血病(ALL)中常见宿主基因组变异的研究进展,指出尽管已发现众多与易感性、疗效和毒性相关的变异,仅TPMT和NUDT15广泛用于临床。文章提出变异临床转化的四个决定特征,并讨论效应量不足、跨人群重复性差等障碍及大规模国际合作等解决途径。
要点
- 仅TPMT和NUDT15变异被广泛用于ALL临床决策。
- 变异临床转化取决于表型严重度、频率、决策支持和干预可行性。
- 大规模国际合作可提升统计效能并支持多基因风险评分等方法。
核心结论
- 常见宿主基因组变异在儿童ALL中与易感性、疗效和毒性相关,但临床转化有限。
- TPMT和NUDT15是仅有的被广泛临床应用的宿主基因组变异。
研究设计与样本
- 综述,总结过去十年宿主基因组变异研究,未报告检索范围与样本量。
主要发现
- 已发现众多常见变异与ALL易感性、治疗 efficacy 和毒性风险相关。
- 少于 handful 的变异达到临床实施,仅TPMT和NUDT15被广泛使用。
- 临床转化主要取决于四个特征:表型严重度、表型稀有性及变异解释的病例比例、作为附加临床决策支持工具的应用、干预或预防措施的可得性、成本及潜在副作用。
- 关键障碍包括效应量不足、缺乏跨多样人群的重复验证及缺乏成熟的治疗调整策略。
- 大规模国际合作可产生必要统计效能,支持多基因风险评分和更先进机器学习策略等复杂生物信息学方法。
关键数值与推荐
- 变异临床转化取决于四个特征:表型严重度、表型稀有性及变异解释的病例比例、作为附加临床决策支持工具的应用、干预或预防措施的可得性、成本及潜在副作用。
- 仅TPMT和NUDT15变异被广泛用于临床。
临床怎么用
- 目前临床实践中可常规考虑TPMT和NUDT15变异检测以指导治疗。
- 其他宿主基因组变异尚未达到临床实施标准,需进一步验证。
局限性
- 许多变异效应量不足,难以临床转化。
- 缺乏跨多样人群的重复验证。
- 缺乏成熟的治疗调整策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Childhood acute lymphoblastic leukemia (ALL) is a genetically heterogeneous disease, and while somatic alterations inform diagnosis and treatment stratification, germline variants - particularly common host genome variants - rarely influence clinical care. Over the past decade, various host genome variant studies have uncovered numerous common variants associated with ALL susceptibility, treatment efficacy, and toxicity risk. Yet, less than a handful have reached clinical implementation, with TPMT and NUDT15 variants being the only ones widely used clinically. Whether a variant can be readily translated into the clinical setting primarily depends on four features: (1) Phenotype severity, (2) phenotype rarity and the proportion of cases (overall or in subsets of patients) accounted for by genetic variants, (3) the application of the variant as an add-on clinical decision support tool, and (4) the availability, cost, and potential side effects of interventions and/or prophylaxis. Key barriers for such clinical translation include insufficient effect sizes, lack of replication across diverse populations, and lack of well-established treatment modification strategies. However, large-scale international collaborations can generate the necessary statistical power, including enabling more complex bioinformatic approaches, such as polygenic risk scores and more advanced machine learning strategies. In this review, we outline the necessary steps toward bridging the gap between genetic discovery and clinical practice.
引用
- Mikkelsen T, Helenius M, Ampatzidou M, et al. Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia. Leukemia. 2025. PMID: 41361660. doi:10.1038/s41375-025-02804-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。